100 related articles for article (PubMed ID: 1461647)
1. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes.
Fisch P; Boehm T; Lavenir I; Larson T; Arno J; Forster A; Rabbitts TH
Oncogene; 1992 Dec; 7(12):2389-97. PubMed ID: 1461647
[TBL] [Abstract][Full Text] [Related]
2. LIM domain proteins in leukaemia and development.
Sánchez-García I; Rabbitts TH
Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
[TBL] [Abstract][Full Text] [Related]
3. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2.
Larson RC; Fisch P; Larson TA; Lavenir I; Langford T; King G; Rabbitts TH
Oncogene; 1994 Dec; 9(12):3675-81. PubMed ID: 7970726
[TBL] [Abstract][Full Text] [Related]
4. Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2.
Sánchez-García I; Axelson H; Rabbitts TH
Oncogene; 1995 Apr; 10(7):1301-6. PubMed ID: 7731680
[TBL] [Abstract][Full Text] [Related]
5. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
6. Developmentally regulated and tissue specific expression of mRNAs encoding the two alternative forms of the LIM domain oncogene rhombotin: evidence for thymus expression.
Boehm T; Spillantini MG; Sofroniew MV; Surani MA; Rabbitts TH
Oncogene; 1991 May; 6(5):695-703. PubMed ID: 2052354
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice.
Larson RC; Osada H; Larson TA; Lavenir I; Rabbitts TH
Oncogene; 1995 Sep; 11(5):853-62. PubMed ID: 7545805
[TBL] [Abstract][Full Text] [Related]
8. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
9. The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development.
Foroni L; Boehm T; White L; Forster A; Sherrington P; Liao XB; Brannan CI; Jenkins NA; Copeland NG; Rabbitts TH
J Mol Biol; 1992 Aug; 226(3):747-61. PubMed ID: 1507224
[TBL] [Abstract][Full Text] [Related]
10. Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma.
Wotton S; Stewart M; Blyth K; Vaillant F; Kilbey A; Neil JC; Cameron ER
Cancer Res; 2002 Dec; 62(24):7181-5. PubMed ID: 12499254
[TBL] [Abstract][Full Text] [Related]
11. The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL).
Royer-Pokora B; Rogers M; Zhu TH; Schneider S; Loos U; Bölitz U
Oncogene; 1995 Apr; 10(7):1353-60. PubMed ID: 7731686
[TBL] [Abstract][Full Text] [Related]
12. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
13. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.
Hunger SP; Cleary ML
Semin Cancer Biol; 1993 Dec; 4(6):387-99. PubMed ID: 8142624
[TBL] [Abstract][Full Text] [Related]
14. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
15. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
Shivdasani RA; Mayer EL; Orkin SH
Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
[TBL] [Abstract][Full Text] [Related]
16. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.
Grütz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH
EMBO J; 1998 Aug; 17(16):4594-605. PubMed ID: 9707419
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain.
Jacobs H; Ossendorp F; de Vries E; Ungewiss K; von Boehmer H; Borst J; Berns A
Oncogene; 1996 May; 12(10):2089-99. PubMed ID: 8668334
[TBL] [Abstract][Full Text] [Related]
20. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
